Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Dunlap

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
European Journal of Heart Failure|April 22, 2021
Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerationsMarat Fudim, Piotr P Ponikowski, Daniel Burkhoff, et al.
European Journal of Heart Failure|December 26, 2006
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARMEldrin F Lewis, Gervasio A Lamas, Eileen O'Meara, et al.
The Lancet. Respiratory Medicine|December 24, 2023
Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trialT Douglas Bradley, Alexander G Logan, Geraldo Lorenzi Filho, et al.
Circulation|October 20, 2004
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trialsJames B Young, Mark E Dunlap, Marc A Pfeffer, et al.
JACC. Heart Failure|December 31, 2016
Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF TrialAndrew P Ambrosy, Lukasz P Cerbin, Paul W Armstrong, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 11, 2016
Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working GroupSean P Collins, Phillip D Levy, Jennifer L Martindale, et al.
Journal of Cardiac Failure|June 6, 2016
Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working GroupSean P Collins, Phillip D Levy, Jennifer L Martindale, et al.
The American Journal of Cardiology|April 26, 2016
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)Marco Metra, Robert J Mentz, Adrian F Hernandez, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
European Journal of Heart Failure|April 22, 2021
Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerationsMarat Fudim, Piotr P Ponikowski, Daniel Burkhoff, et al.
European Journal of Heart Failure|December 26, 2006
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARMEldrin F Lewis, Gervasio A Lamas, Eileen O'Meara, et al.
The Lancet. Respiratory Medicine|December 24, 2023
Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trialT Douglas Bradley, Alexander G Logan, Geraldo Lorenzi Filho, et al.
Circulation|October 20, 2004
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trialsJames B Young, Mark E Dunlap, Marc A Pfeffer, et al.
JACC. Heart Failure|December 31, 2016
Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF TrialAndrew P Ambrosy, Lukasz P Cerbin, Paul W Armstrong, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 11, 2016
Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working GroupSean P Collins, Phillip D Levy, Jennifer L Martindale, et al.
Journal of Cardiac Failure|June 6, 2016
Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working GroupSean P Collins, Phillip D Levy, Jennifer L Martindale, et al.
The American Journal of Cardiology|April 26, 2016
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)Marco Metra, Robert J Mentz, Adrian F Hernandez, et al.
Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
Pageof 6